Combining T-VEC and pembrolizumab does not significantly improve survival in advanced, unresectable melanoma Presented ByDr Helen Gogas, National and Kapodistrian University of Athens, Greece TrialPhase 3, MASTERKEY-265 ConferenceESMO 2021 19 November, 2021 09:30